Menu
Not yet recruiting NCT07741409

Povidone Iodine for Caries Prevention

Phase III Interventional Dental Caries

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Povidone Iodine 5% Soln,Top,Kit, Probiotics, Placebo.
Who it may be relevant to
Registry conditions: Dental Caries. Basic parameters: 1 year — 3 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Povidone Iodine to Prevent Early Childhood Caries

Overview

The goal of this clinical trial is to learn if Povidone Iodine works to prevent tooth decay and suppress the mouth germs responsible for tooth decay. The main questions it aims to answer are: 1. How will home use of Povidone Iodine, as an adjunct treatment to standard dental care, reduce the incidence of tooth decay? 2. How will home use of Povidone Iodine reduce the mouth germs responsible for tooth decay? 3. If Povidone Iodine use is accompanied by probiotic use, will its effectiveness be even better than Povidone Iodine alone? Participants will: 1. Provide a plaque sample at the beginning of the study. 2. Swab their children's teeth once a week for one month and then monthly thereafter. Some participants may be asked to use probiotic drops nightly after brushing their teeth. 3. Keep a record of compliance. 4. Return every 6 months for a dental exam and to provide a plaque sample. Keep a diary of their symptoms and the number of times they use a rescue inhaler

Detailed description

Dental 'caries' is the term used to describe dental decay or 'cavities'. Dental caries can occur at any age but lesions prior to a child's 6th birthday qualify as 'early childhood caries' (ECC) and possibly as 'severe' early childhood caries (SECC) if the onset and severity meet definitions put forth by the American Academy of Pediatric Dentistry. ECC and SECC can have several unfortunate downstream consequences: pain, infection, nutritional deficiencies, poorer concentration in school, and social/cosmetic/financial concerns. Recent epidemiologic trends in ECC/SECC, reported by Kotha et al. (2022) based on data from the National Health and Nutrition Examination Survey (NHANES), have found little change in prevalence over the span from 2013 to 2018 with approximately 20% of children experiencing ECC by age 3 years with over half that percentage categorized as having SECC. Thus, there remains a critical need to improve prevention and treatment strategies.

Many variables can affect the likelihood of developing dental decay but prominent among these are excess consumption of sugary foods and drinks, inadequate oral hygiene, and poor access to dental care and oral health educational resources. Ultimately, microbes on the surface of teeth convert dietary sugar to acid that dissolves enamel thereby initiating and advancing decay. Brushing regularly with fluoridated toothpaste helps suppress the microbial population which decreases the acid challenge while fluoride promotes remineralization of enamel. Seeing a dentist regularly can ensure that any decay that develops is treated at its earliest stages thereby saving teeth.

While prevention strategies work well for many individuals, for a multitude of potential reasons they may prove inadequate for others. In particular, children with poor access to professional care or who are disadvantaged in other respects frequently fail to realize the benefits of the current standard of care.

The objective of this investigation is to test the effectiveness of povidone iodine (PI) as a home-administered preventive or treatment for dental caries that, unlike other treatment options, addresses the underlying cause - dental plaque that has an overabundance of strong acid-producing bacterial species. This imbalance of strong acid producers is referred to as a 'dysbiosis'. We will also test whether combining PI with probiotics - living microbes that can be used to boost health - will have a greater benefit than PI alone in maintaining or restoring a healthy microbial composition to dental plaque. We are in a unique position to leverage our access to children at high risk for decay to test multiple integrated hypotheses that we predict will result in more effective home dental care, and significant reductions in the incidence and severity of dental decay that is longer lasting than is possible with the current standard of care.

Despite tremendous advances in understanding how particular microbes in dental plaque lead to tooth decay, prevention and treatment options remain non-specific - dedicated to plaque control rather than to replacing the offending microbes with health-related species (correcting the dysbiosis). This limitation results in the chronic presence of an elevated microbial risk that likely proves most consequential in individuals with limited access to professional care and suboptimal oral hygiene habits. Importantly, PI is unique among current standard of care options because there is evidence that it not only can prevent caries but that it also attacks the microbial offenders that drive caries development. The addition of fluoride to water supplies and oral health care products was a game-changer. Protection appears to be due to improving the enamel remineralization/demineralization balance rather than any antimicrobial activity despite in vitro evidence of selective toxicity against S. mutans.

Consequently, fluoride is excellent at caries prevention (when available/applied in adequate amounts and frequency) but does not improve a dysbiotic plaque microbiome. Chlorhexidine, sometimes prescribed for individuals with rampant caries, is considered the 'gold-standard' of anti-plaque agents but a large NIDCR-sponsored study (Papas et al., 2012) found no greater protection against caries than the use of fluoride alone.

Additionally, chlorhexidine use does not appear to remedy a cariogenic dysbiosis. Silver products have a long history in dental treatment and have generated renewed interest in recent years. The strong staining properties of silver, however, limit its application. The preponderance of evidence does not support a role for silver in improving a cariogenic microbial dysbiosis but further investigation is necessary.

Iodine, like silver, has long been recognized for its antiseptic/antimicrobial properties. Combining iodine with povidone improves water solubility. Evidence to date suggests that PI offers the greatest breadth of desirable properties but additional investigation is necessary in order to make a strong case for widespread adoption by clinicians. This proposal seeks to document the effectiveness of home use of PI for providing long-term reduction in caries risk by reducing the microbial dysbiosis within cariogenic dental plaque.

Hypothesis(es) and objective(s): We hypothesize that home use of PI will reduce the incidence and severity of dental decay in a high-risk population of children. Though not a substitute for proper oral hygiene such as brushing twice a day for two minutes each, its application is so quick that compliance is more likely than engaging in routine, effective oral hygiene and it would likely boost the effectiveness of imperfect oral hygiene practices. We further hypothesize that PI has selective toxicity for oral pathogens and its use would improve the microbial make-up of dental plaque thereby helping sustain beneficial effects. Finally, we hypothesize that this latter property of PI can be combined with probiotic administration to elevate the beneficial effect.

Study Protocol:

Patient Pool: The patient pool will be children of ages 1 to 3 years old who receive care

through the Infant Oral Health clinic that is part of the Iowa City Women, Infant, Children (WIC) Program in Iowa City. The University of Iowa Department of Pediatric Dentistry has an ongoing collaboration with the IC-WIC to provide oral health care and sees 16 to 24 children per week (Weber-Gasparoni et al., 2010). The children are typically from low-income families and all are at high risk for decay. We estimate that we could recruit 3 to 5 subjects/week. To estimate the number of subjects necessary to obtain statistically significant results, we extrapolated from the results of Lopez et al. (2002) who used 10% povidone iodine and an outcome measure of new caries. Based on the

differences between treatment and placebo groups, 126 subjects (42 Group 1, PI; 42 Group 2, PI + probiotics; and 42 Group 3, placebo) would give 80% power to determine a statistical difference in caries outcome with an alpha error of 0.05. To meet this number, we will enroll 174 subjects to account for an estimated 27% annual attrition.

Subjects will be randomly assigned to Groups 1, 2 or 3. However, if a subject consents to use PI but not probiotics, their assignment will be to either Group 1 or Group 3. We anticipate completing enrollment during year 1 of the study but have reserved 18 months to meet the recruitment goal. We also want to make clear that Group 3 will be the placebo group for the Group 1 iodine treatment. After considerable contemplation, we decided against including a strict placebo group for the probiotic administration. We considered having Group 3 use both the PI placebo and probiotic placebo but that would 'muddy' the analytical comparison with Group 1 (PI alone). Including another distinct placebo group would add considerable expense to the project that might not be justified if compliance with a daily regimen turned out to be low. As designed, we feel this project will yield strong data for the efficacy of home use of PI. The inclusion of a probiotic group has the potential to add significant insight into the mechanism by which PI exerts any observed benefit, or it may offer a lesson in the limits of compliance for any sort of daily oral health promoting regimen.

Enrollment and Visit Protocols: Pediatric Dental Residents will be the practitioners

treating the prospective participants. They will be calibrated with respect to caries scoring (ICDAS) prior to initiating the study. Once it is determined that the subjects satisfy the inclusion criteria (child of appropriate age; no imminent plans to relocate), they will follow an IRB-approved recruitment/enrollment protocol that will also determine

if any exclusion criteria (thyroid condition; antibiotic usage in the prior 3 months) apply. Once informed consent is obtained, the current caries status will be recorded and a pooled plaque sample will be taken using a sterile foam-tipped applicator (Puritan®) and swabbing all exposed tooth surfaces. The study coordinator will provide the practitioner with PI (Povi-One povidone iodine unit dose kit; Elevate Oral Care®), PI and probiotic drops (Prodentis by BioGaia), or placebo (colored tea for PI). The practitioner will apply the PI treatment onto the teeth of the participant and instruct them in home use. For participants given probiotic, verbal instructions will be provided to administer the drops once a day after brushing before bedtime. While this protocol precludes keeping practioners blinded with respect to the intervention, only the study coordinator will keep a record of the participants' group assignment so that practioners will not have access to group assignment records at follow-up appointments thereby minimizing the possibility of bias in subsequent caries evaluations. The PI protocol will be one application per week for one month and then once a month thereafter. Probiotic application will be daily. The concentration of the povidone iodine will be 5% and the maximum dose of probiotic will be 5 drops. The amount disbursed in an application and the frequency of application will be well within the safety margins for iodine exposure (Frank et al., 2020). Subjects will receive reminders ahead of a scheduled home application of PI via text message or communication method of choice to help ensure compliance. Subjects will also have the opportunity to reply to the messaging so that compliance can be tracked and/or keep a home diary of compliance and personal oral hygiene habits (How many times per day/week do the children brush? Themselves or by parents? Does the toothpaste contain fluoride?). At each 6-month follow-up

appointment, subjects will again have their caries status recorded and provide a pooled-plaque sample. They will also be asked questions related to use of antibiotics during the period between baseline and follow-up appointments. Maximal duration of participation for any subject will be 1 year.

Processing of Plaque Samples for Microbiome Analysis: Pooled plaque samples will be

collected as described above. The foam tip of the applicator will be broken off into 300ul RNAlater™ (Invitrogen) for transport to lab and isolation of DNA using the Qiagen DNeasy PowerLyzer PowerSoil Kit. The DNA that is recovered contains strands from all the microbes present in the sample. Technology allows the DNA to be sequenced and computational software is capable of analyzing the sequences and providing a breakdown of the proportional representation of the different types of microbes present. To accomplish this, the DNA samples will be sent to LC Sciences (Houston, TX) for the sequencing and microbial data analysis. \[For those technically inclined, the 16S sequencing primers will target the V3 and V4 regions. The resulting 465bp amplicon will be sequenced on a NovaSeq platform with 250bp paired-end reads. Raw data files will be

Interventions

  • Drug Povidone Iodine 5% Soln,Top,Kit
    Home use of Povidone Iodine administered by swabbing teeth; weekly for the 1st month, monthly thereafter.
  • Dietary supplement Probiotics
    Home use of Povidone Iodine coupled with daily use of a probiotic.
  • Drug Placebo
    Placebo for the Povidone Iodine

Primary outcome measures

  • Prevention of Dental Caries [Time frame: Minimum 6 months; maximum 12 months]
Secondary outcome measures (1)
  • Microbiome [Time frame: Minimum 6 months; maximum 12 months]

Eligibility criteria

Inclusion criteria

  • 1 to 3 years of age
  • No plans to relocate in the next 12 months

Exclusion criteria

  • Thyroid condition
  • Antibiotic usage in the prior 3 months

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Single group
Masking
Double blind
Primary purpose
Prevention

Study locations

United States · 1 center
  • University of Iowa College of Dentistry — Iowa City

Publications

  • Milgrom P, Tut O, Rothen M, Mancl L, Gallen M, Tanzer JM. Addition of Povidone-Iodine to Fluoride Varnish for Dental Caries: A Randomized Clinical Trial. JDR Clin Trans Res. 2021 Apr;6(2):195-204. doi: 10.1177/2380084420922968. Epub 2020 May 21. PMID 32437626
  • Lyashenko C, Herrman E, Irwin J, James A, Strauss S, Warner J, Khor B, Snow M, Ortiz S, Waid E, Nasry B, Chai J, Choong C, Palmer E, Kutsch K, Forsyth A, Choi D, Maier T, Machida CA. Adjunctive dental therapies in caries-active children: Shifting the cariogenic salivary microbiome from dysbiosis towards non-cariogenic health. Hum Microb J. 2020 Dec;18:100077. doi: 10.1016/j.humic.2020.100077. Epub PMID 34485763
  • Li Y, Tanner A. Effect of Antimicrobial Interventions on the Oral Microbiota Associated with Early Childhood Caries. Pediatr Dent. 2015 May-Jun;37(3):226-44. PMID 26063552
  • Muntean A, Mzoughi SM, Pacurar M, Candrea S, Inchingolo AD, Inchingolo AM, Ferrante L, Dipalma G, Inchingolo F, Palermo A, Bordea IR. Silver Diamine Fluoride in Pediatric Dentistry: Effectiveness in Preventing and Arresting Dental Caries-A Systematic Review. Children (Basel). 2024 Apr 22;11(4):499. doi: 10.3390/children11040499. PMID 38671716
  • Papas AS, Vollmer WM, Gullion CM, Bader J, Laws R, Fellows J, Hollis JF, Maupome G, Singh ML, Snyder J, Blanchard P; PACS Collaborative Group. Efficacy of chlorhexidine varnish for the prevention of adult caries: a randomized trial. J Dent Res. 2012 Feb;91(2):150-5. doi: 10.1177/0022034511424154. Epub 2011 Dec 7. PMID 22156917
  • Bokulich NA, Kaehler BD, Rideout JR, Dillon M, Bolyen E, Knight R, Huttley GA, Gregory Caporaso J. Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2's q2-feature-classifier plugin. Microbiome. 2018 May 17;6(1):90. doi: 10.1186/s40168-018-0470-z. PMID 29773078
  • Sulyanto RM, Beall CJ, Berger MT, Goodell CP, Koo S, Candamo F, Dickson JR, Kang M, Ho SP, Ng MW, Hashmi SB, Leys EJ, Griffen AL. Silver diamine fluoride alters microbial communities in subsurface dentin. JADA Found Sci. 2022 Feb 8;1:100004. doi: 10.1016/j.jfscie.2021.100004. eCollection 2022. PMID 42238656
  • Zhang JS, Chen Z, Chu CH, Yu OY. Effect of silver diamine fluoride upon the microbial community of carious lesions: A scoping review. J Dent. 2023 Jul;134:104554. doi: 10.1016/j.jdent.2023.104554. Epub 2023 May 21. PMID 37220834

Identifiers

NCT: NCT07741409 · 202601408 · N063700-G

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗